Dataset Viewer
smiles
string | doi
string | title
string | publisher
string | year
int64 | access
int64 | compound_id
string | target_type
string | target_relation
string | target_value
string | target_units
string | bacteria
string | bacteria_name_unified
string | bacteria_info
string | page_bacteria
int64 | origin_bacteria
string | section_bacteria
string | subsection_bacteria
string | page_target
int64 | origin_target
string | section_target
string | subsection_target
float64 | column_prop
string | line_prop
float64 | page_scaffold
int64 | origin_scaffold
string | section_scaffold
string | subsection_scaffold
float64 | page_residue
float64 | origin_residue
string | section_residue
string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC=C3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 1 | pMIC | '=' | 5,52 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)C=O)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 2 | pMIC | '=' | 6,16 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)C=NO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 3 | pMIC | '=' | 5,76 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)C=NOC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 4 | pMIC | '=' | 5,59 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 5 | pMIC | '=' | 5,86 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)CO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 6 | pMIC | '=' | 5,56 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)C(=O)OC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 7 | pMIC | '=' | 5,29 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)C(=O)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 8 | pMIC | '=' | 4,37 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CCOC(=O)C=CC1=CN(C=C1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 9 | pMIC | '=' | 5,03 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CCOC(=O)CCC1=CN(C=C1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 10 | pMIC | '=' | 5,04 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)CCCO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 11 | pMIC | '=' | 4,99 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=C3)CCCNS(=O)(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 12 | pMIC | '=' | 4,77 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(=O)C1=CN(C=C1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 13 | pMIC | '=' | 5,27 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
CC(C1=CN(C=C1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F)O | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 14 | pMIC | '=' | 4,37 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
O=C1N(C2=CC(F)=C(C=C2)N3C=C(C(=NO)C)C=C3)C[C@H](CNC(C)=O)O1 | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 15 | pMIC | '=' | 5,29 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 3 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 3 | table 1 | null |
O=C1N(C2=CC(F)=C(C=C2)N3C=C(C(=NOC)C)C=C3)C[C@H](CNC(C)=O)O1 | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 16 | pMIC | '=' | 5,01 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC=N3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 17 | pMIC | '=' | 5,22 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CCOC(=O)C1=CN(N=C1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 18 | pMIC | '=' | 5,01 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(C=N3)C(=O)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 19 | pMIC | '=' | 4,37 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
O=C1N(C2=CC(F)=C(C=C2)N3C=C(C(NC)=O)C=N3)C[C@H](CNC(C)=O)O1 | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 20 | pMIC | '=' | 4,39 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(C=N3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 21 | pMIC | '=' | 5,86 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(C=N3)I)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 22 | pMIC | '=' | 5,36 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(C=N3)NC(=O)OC(C)(C)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 23 | pMIC | '=' | 4,75 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(C=N3)NC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 24 | pMIC | '=' | 4,41 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(C=N3)C#C[Si](C)(C)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 25 | pMIC | '=' | 5,03 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(C=N3)C#C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 26 | pMIC | '=' | 5,25 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)C(F)(F)F)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 27 | pMIC | '=' | 5 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)NC(=O)OC(C)(C)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 28 | pMIC | '=' | 5,05 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 29 | pMIC | '=' | 5,24 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 4 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 4 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)NC(=O)CO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 30 | pMIC | '=' | 4,41 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)NC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 31 | pMIC | '=' | 4,71 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)NS(=O)(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 32 | pMIC | '=' | 4,43 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 33 | pMIC | '=' | 5,56 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC1=NN(C=C1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 34 | pMIC | '=' | 4,94 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=O)N3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 35 | pMIC | '=' | 4,64 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)OC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 36 | pMIC | '=' | 4,71 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CC(=N3)OC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 37 | pMIC | '=' | 4,96 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CN=C3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 38 | pMIC | '=' | 5,22 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=C3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 39 | pMIC | '=' | 4,95 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=CN=N3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 40 | pMIC | '=' | 5,53 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)C1=CN(N=N1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 41 | pMIC | '=' | 5,58 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=NO)C1=CN(N=N1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 42 | pMIC | '=' | 4,99 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)C(=O)OC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 43 | pMIC | '=' | 4,99 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 44 | pMIC | '=' | 5,56 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 5 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 5 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)C=O)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 45 | pMIC | '=' | 5,86 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)C(=O)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 46 | pMIC | '=' | 4,98 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)C(=O)NC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 47 | pMIC | '=' | 4,69 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)CO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 48 | pMIC | '=' | 4,96 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)C=NO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 49 | pMIC | '=' | 4,68 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=C(N=N3)C=NOC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 50 | pMIC | '=' | 4,99 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3N=CC=N3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 51 | pMIC | '=' | 4,92 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3N=CC(=N3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 52 | pMIC | '=' | 5,86 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC=N3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 53 | pMIC | '=' | 4,92 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)C(=O)OC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 54 | pMIC | '=' | 4,39 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)CO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 55 | pMIC | '=' | 4,36 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)C=O)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 56 | pMIC | '=' | 4,96 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)C(=O)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 57 | pMIC | '=' | 4,37 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 58 | pMIC | '=' | 4,96 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 6 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 6 | table 1 | null |
CC1=NN(C=N1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 59 | pMIC | '=' | 4,64 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)NC(=O)CC4=CC=CC=C4)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 60 | pMIC | '=' | 4,47 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 61 | pMIC | '=' | 4,64 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NC(=N3)Cl)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 62 | pMIC | '=' | 4,97 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NN=C3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 63 | pMIC | '=' | 4,32 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3N=CN=N3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 64 | pMIC | '=' | 5,23 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3N=C(N=N3)C=O)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 65 | pMIC | '=' | 4,66 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
O=C1N(C2=CC(F)=C(C=C2)N3N=C(C=NO)N=N3)C[C@H](CNC(C)=O)O1 | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 66 | pMIC | '=' | 4,98 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3N=C(N=N3)C#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 67 | pMIC | '=' | 5,26 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3C=NN=N3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 68 | pMIC | '=' | 4,93 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=CS3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 69 | pMIC | '=' | 5,53 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NNC(=O)S3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 70 | pMIC | '=' | 5,55 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC1=NN=C(S1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 71 | pMIC | '=' | 5,55 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CCC1=NN=C(S1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 72 | pMIC | '=' | 5,56 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 7 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 7 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CF)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 73 | pMIC | '=' | 5,57 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)COC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 74 | pMIC | '=' | 5,28 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)COC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 75 | pMIC | '=' | 5,63 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CCOC(=O)C1=NN=C(S1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 76 | pMIC | '=' | 4,71 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)CCC1=NN=C(S1)C2=C(C=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 77 | pMIC | '=' | 5,61 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CC#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 78 | pMIC | '=' | 5,27 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CSC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 79 | pMIC | '=' | 5,6 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 80 | pMIC | '=' | 5,56 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)C(=O)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 81 | pMIC | '=' | 5,88 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CC(=O)N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 82 | pMIC | '=' | 4,99 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
O=C1N(C2=CC(F)=C(C=C2)C=3SC(CCC(=NO)C)=NN3)C[C@H](CNC(C)=O)O1 | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 83 | pMIC | '=' | 5,32 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CS(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 84 | pMIC | '=' | 4,71 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CS(=O)(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 85 | pMIC | '=' | 5,03 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CN)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 86 | pMIC | '=' | 4,66 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 8 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 8 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CNC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 87 | pMIC | '=' | 4,98 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=S)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CS(=O)(=O)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 89 | pMIC | '=' | 6,25 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=S)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CN)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 90 | pMIC | '=' | 5,88 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=S)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN=C(S3)CNC)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 91 | pMIC | '=' | 5,9 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=NN3)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 92 | pMIC | '=' | 4,9 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=NN3C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 93 | pMIC | '=' | 5,52 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=NN3CCO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 94 | pMIC | '=' | 4,36 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=NN3CCC#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 95 | pMIC | '=' | 4,37 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
C(C=C)N1C(=CC=N1)C2=C(F)C=C(C=C2)N3C[C@H](CNC(C)=O)OC3=O | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 96 | pMIC | '=' | 4,65 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN(C=C3)C)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 97 | pMIC | '=' | 4,62 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN(C=C3)CCO)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 98 | pMIC | '=' | 4,36 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN(C=C3)CCC#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 99 | pMIC | '=' | 4,97 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | Materials and methods | Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
O=C1N(C2=CC(F)=C(C=C2)C3=NN(CC=C)C=C3)C[C@H](CNC(C)=O)O1 | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 100 | pMIC | '=' | 4,65 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | 2. Materials and methods | 2.1 Data set and descriptor calculation | 9 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 9 | table 1 | null |
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=NN(C=C3)CC#N)F | 10.1080/08927020601188528 | QSAR study of oxazolidinone antibacterial agents using artificial neural networks | Informa UK Limited | 2,007 | 0 | 101 | pMIC | '=' | 5,25 | mol/l | methicillin-susceptible S. aureus | Staphylococcus aureus | Methicillin susceptible | 2 | text | 2. Materials and methods | 2.1 Data set and descriptor calculation | 10 | table 1 | null | null | null | null | 2 | figure 1 | null | null | 10 | table 1 | null |
End of preview. Expand
in Data Studio
Dataset Card for Oxazo Dataset
This dataset contains chemical and biological data on oxazolidinone derivatives with antibacterial activity. It includes SMILES structures, target values (e.g., pMIC), and bacteria-related annotations extracted from publications.
Dataset Summary
- Number of rows: 2,923
- Number of columns: 31
- Data type: CSV
- Missing values: Present in annotation-related fields
Column Examples
smiles: Molecular structuretarget_value,target_type: Biological activitybacteria,bacteria_info: Target organismpublisher,doi,title: Source article info
Potential Uses
- QSAR modeling
- Antibacterial activity prediction
- Drug discovery research
License
MIT
2025-04-18
- Downloads last month
- 54